August 4, 2022

Eisai Presents New Findings on Lecanemab’s Investigational Subcutaneous Formulation and Modeling Simulation of ApoE4 Genotype on Aria-E Incidence at AAIC 2022

TOKYO and CAMBRIDGE, Mass., Aug 4, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced that Eisai presented new findings…

March 18, 2022

诺辉健康发布2021年报：营收同比增长202%，毛利率攀升至72.7%

HANGZHOU, Mar 18, 2022 – (亚太商讯 via SEAPRWire.com) – 中国领先的癌症早筛生物高科技公司诺辉健康（6606.HK）今日发布2021年截至12月31日的年度业绩报告。诺…